Correlation between thymidylate synthase protein expression and gene polymorphism with clinicopathological parameters in colorectal carcinoma

International Journal of Surgical Pathology

Volumn 17, Issue 3, 2009, Pages 181-186

  Moreira, Luciana R ^a   Almeida Schenka, André ^a   Latuff Filho, Paulo ^a   Nascimento, Helvia ^a   Passos Lima, Carmen Silvia ^a   Silva Trevisan, Miriam Aparecida ^a   Vassallo, José ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Colorectal carcinoma; Gene polymorphism; Immunohistochemistry; Polymerase chain reaction; Prognosis; Thymidylate synthase

Indexed keywords

DNA; FLUOROURACIL; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DNA POLYMORPHISM; FEMALE; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 65849467964     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896908330480     Document Type: Article

References (37)

1. Assaraf YG Molecular basis of antifolate resistance. Cancer Metastasis Rev. 2007 ; 26: 153-181.
2. Sharp L., Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004 ; 159: 423-443.
3. Danenberg PV, Langenbach RJ, Heidelberger C. Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. Biochemistry. 1974 ; 13: 926-933.
4. Kufe DW, Major PP, Egan EM, Loh E. 5-Fluoro-2ĝ€2deoxyuridine incorporation in L1210 DNA. J Biol Chem. 1981 ; 256: 8885-8888.
5. Danenberg PV, Heidelberger C., Mulkins MA, Peterson AR The incorporation of 5-fluoro-2ĝ€2-deoxyuridine into DNA of mammalian tumor cells. Biochem Biophys Res Commun. 1981 ; 102: 654-658.
6. Danenberg PV, Lockshin A. Thymidylate synthetase-substrate complex formation. Mol Cell Biochem. 1982 ; 43: 49-57.
7. Allen WL, Johnston PG Role of genomic markers in colorectal cancer treatment. J Clin Oncol. 2005 ; 23: 4545-4552.
8. Yamachika T., Nakanishi H., Inada K., et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer. 1998 ; 82: 70-77.
9. Nanni O., Volpi A., Frassineti GL, et al. Role of biological markers in the clinical outcome of colon cancer. Br J Cancer. 2002 ; 87: 868-875.
10. Gonen M., Hummer A., Zervoudakis A., et al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol. 2003 ; 21: 406-412.
11. Matsui T., Omura K., Kawakami K., Morita S., Sakamoto J. Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer. Oncol Rep. 2006 ; 16: 1111-1115.
12. Jakobsen A., Nielsen JN, Gyldenkerne N., Lindeberg J. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity. J Clin Oncol. 2005 ; 23: 1365-1369.
13. Popat S., Matakidou A., Houlston RS Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2004 ; 22: 529-536.
14. Popat S., Wort R., Houlston RS Relationship between thymidylate synthase (TS) genotype and TS expression: a tissue microarray analysis of colorectal cancers. Int J Surg Pathol. 2005 ; 13: 127-133.
15. Atkin G., Barber PR, Vojnovic B., Daley FM, Glynne-Jones R., Wilson GD Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer. Hum Pathol. 2005 ; 36: 1302-1308.
16. Horie N., Aiba H., Oguro K., Hojo H., Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5ĝ€2- terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct. 1995 ; 20: 191-197.
17. Goldberg RM, Sargent D., Mahoney MR, et al. Limited prognostic importance of immunohistochemical parameters (thymidylate synthase, Ki-67 and p-53) in 465 patients with Dukes' B2 and C colon cancer enrolled on North Central Cancer Treatment Group (NCCTG) Trials [Abstract 1027]. Paper presented at: 35th Annual Meeting of the American Society of Clinical Oncology ; May 15-18, 1999 ; Atlanta, GA.
18. Duffy MJ, van Dalen A., Haglund C., et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007 ; 43: 1348-1360.
19. Locker GY, Hamilton S., Harris J., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006 ; 24: 5313-5327.
20. Tomiak A., Vincent M., Earle CC, et al. Thymidylate synthase expression in stage II and III colon cancer: a retrospective review. Am J Clin Oncol. 2001 ; 24: 597-602.
21. Johnston PG, Benson AB 3rd, Catalano P., Rao MS, O'Dwyer PJ, Allegra CJ Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J Clin Oncol. 2003 ; 21: 815-819.
22. Findlay MP, Cunningham D., Morgan G., Clinton S., Hardcastle A., Aherne GW Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy. Br J Cancer. 1997 ; 75: 903-909.
23. Saw RP, Morgan M., Koorey D., et al. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Dis Colon Rectum. 2003 ; 46: 192-202.
24. Yamada T., Tanaka N., Yokoi K., et al. Correlation between clinical pathologic factors and activity of 5-FU-metabolizing enzymes in colorectal cancer. J Nippon Med Sch. 2008 ; 75: 23-27.
25. Aschele C., Debernardis D., Casazza S., et al. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J Clin Oncol. 1999 ; 17: 1760-1770.
26. Lenz HJ, Danenberg KD, Leichman CG, et al. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res. 1998 ; 4: 1227-1234.
27. Davies MM, Johnston PG, Kaur S., Allen-Mersh TG Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine. Clin Cancer Res. 1999 ; 5: 325-328.
28. Allegra CJ, Parr AL, Wold LE, et al. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J Clin Oncol. 2002 ; 20: 1735-1743.
29. Farrugia DC, Ford HE, Cunningham D., et al. Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. Clin Cancer Res. 2003 ; 9: 792-801.
30. Allegra CJ, Paik S., Colangelo LH, et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol. 2003 ; 21: 241-250.
31. Bissoon-Haqqani S., Moyana T., Jonker D., Maroun JA, Birnboim HC Nuclear expression of thymidylate synthase in colorectal cancer cell lines and clinical samples. J Histochem Cytochem. 2006 ; 54: 19-29.
32. Johnston PG, Liang CM, Henry S., Chabner BA, Allegra CJ Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res. 1991 ; 51: 6668-6676.
33. Wong NA, Brett L., Stewart M., et al. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Br J Cancer. 2001 ; 85: 1937-1943.
34. Edler D., Glimelius B., Hallström M., et al. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. Clin Oncol. 2002 ; 20: 1721-1728.
35. Gorlick R., Metzger R., Danenberg KD, et al. Higher levels of thymidylate synthase gene expression are in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol. 1998 ; 16: 1465-1469.
36. Cascinu S., Aschele C., Barni S., et al. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Clin Cancer Res. 1999 ; 5: 1996-1999.
37. Ohrling K., Edler D., Hallström M., Ragnhammar P. Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours. Anticancer Res. 2008 ; 28 (3B). 1741-1747.